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Periodontitis has been associated with increased serum 
C-reactive protein (CRP) levels, a marker for systemic inflam-
mation (Ebersole et al. 1997; Slade et al. 2003), leading to the 
hypothesis that periodontitis might increase serum mediators 
of systemic inflammation and risk of systemic inflammatory 
diseases (Noack et al. 2001). Mechanistically, bacteremia, the 
entry of plaque microbial toxins/molecules into the circulation, 
and/or release of cytokines from the inflamed periodontium 
could induce systemic inflammatory mediators (Offenbacher 
et al. 1999), thereby prompting expression and release of acute 
phase reactants (e.g., CRP) from the liver and other tissues. 
Systemic inflammation has been implicated as having a possi-
ble etiologic role in cardiovascular disease (Libby 2002), pre-
term birth (Romero et al. 2006), and other systemic diseases. 
Therapeutic interventions that improve periodontal health have 
been reported to decrease serum CRP (Ebersole et al. 1997; 
D’Aiuto et al. 2004; Koromantzos et al. 2012). Others, how-
ever, have not shown decreased CRP following periodontal 
therapy (Ioannidou et al. 2006). Moreover, intervention trials 
have not reproducibly demonstrated that treatment of peri-
odontitis improves clinical outcomes in cardiovascular disease 
(Offenbacher, Beck, Moss, et al. 2009; Tonetti 2009) or pre-
term birth (Offenbacher, Beck, Jared, et al. 2009) patient 
populations. Clearly, mechanistic insights are needed to further 
explain the association of periodontitis with systemic inflammatory 
conditions.
Subjects differ in genetics, medical history, physiologic status, 
and behavior and can differ in immune and inflammatory response 
to infectious challenge (Barreiro and Quintana-Murci 2010) and 
in response to therapy (Kalow 1997). Identifying subject differ-
ences that shape systemic responses to periodontitis will be impor-
tant to determining if subject subgroups differ in risk of systemic 
consequences from periodontitis and its treatment.
Previously, we reported (Singer et al. 2009) that physiologic 
increases in serum 8-isoprostane levels, a stable lipid marker of 
oxidative stress, are associated with decreased serum IgG 
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Abstract
In a previous report, we demonstrated the inverse association of high serum 8-isoprostane levels, a marker for oxidative stress, with 
decreased serum IgG antibodies to oral bacteria. The association between increased serum IgG with increased plaque and periodontitis 
(increased probing depths) was attenuated by high systemic oxidative stress. Other investigations have reported a role for systemic 
oxidative stress as a stimulus of hepatic C-reactive protein (CRP) response. These observations led us to hypothesize that the reported 
relationship of periodontitis to elevated serum CRP, a systemic inflammatory marker, may be modified by oxidative stress and that the 
levels of serum antibodies to oral bacteria might be an intermediary explanatory variable linking the association of systemic oxidative 
stress, periodontal disease, and levels of CRP. This hypothesis was explored as a secondary analysis of the Dental ARIC (Atherosclerosis 
Risk in Communities) study using serum levels of CRP, serum IgG levels to 16 oral organisms, serum levels of 8-isoprostane, and 
periodontal status. The findings indicate periodontitis is associated with high CRP in the presence of elevated oxidative stress that serves 
to suppress the IgG response. Only within the highest 8-isoprostane quartile was periodontitis (pocket depth) associated with increased 
serum CRP levels (P = 0.0003). Increased serum IgG antibody levels to oral bacteria were associated with lowered serum CRP levels. 
Thus, systemic oxidative stress, which has been demonstrated to be associated with increased levels of CRP in other studies, appears to 
be associated with the suppression of bacterial-specific IgG levels, which in the presence of periodontal disease can result in an enhanced 
systemic CRP response. Conversely, individuals with increased serum IgG antibodies to plaque bacteria exhibit lowered serum CRP 
levels. These 2 factors, oxidative stress and the serum IgG response, appear to function in opposing directions to modify serum levels 
of CRP and the association with periodontitis.
Keywords: biomarkers, biostatistics, bacteria, host pathogen interaction, acute phase reaction, immunity 
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antibody levels against 17 oral bacteria, including periodontal 
pathogens. Quartiles of increased serum 8-isoprotane were 
associated with significant decreases in all 17 serum IgG anti-
bodies. Of particular interest, only subjects in the lowest quar-
tile of serum 8-isoprostane concentration had increased serum 
IgG antibody levels in the presence of elevated (top quartile) 
plaque (or plaque [percent sites with Plaque Index ≥1] plus 
pocket depth [top quartile number of pockets ≥5 mm]). Thus, 
physiologic differences in a lipid marker of systemic oxidative 
stress identified subject subset(s) with decreased/increased serum 
IgG antibody responses to oral bacteria and periodontitis.
Several studies have reported the association between ele-
vated serum CRP levels and increased systemic 8-isoprostane 
levels (Handelman et al. 2001; Cottone et al. 2007; Dohi et al. 
2007). In humans, the CRP gene promoter sequence contains a 
nuclear factor (NF)–κB binding site (Voleti and Agrawal 
2005), which responds to oxidative stress to enhance expres-
sion (Schreck et al. 1992). The systemic levels of oxidative 
stress represent a balance of oxidative exposures, including 
bacterial, traumatic, and ischemic challenges to tissues in the 
milieu of dietary influenced levels of lipid and water-soluble 
antioxidants. In the present investigation, we conducted a sec-
ondary analysis to examine whether the association between 
periodontal disease and elevated CRP was associated with 
physiologic differences in oxidative stress (serum 8-isoprostane 
levels) and whether this association was modified by the levels 
of serum IgG antibodies to oral bacteria. We hypothesized that 
high oxidative stress would be associated with low IgG levels 
to oral bacteria, which in the presence of periodontal disease 
would have the potential to result in greater hepatic exposure to 
oral organisms and further increase serum CRP levels. Stated 
another way, we hypothesized high IgG antibody responses 
(possibly blocking invasion) might be expected to decrease the 




The Atherosclerosis Risk in Communities (ARIC) study 
(Atherosclerosis Risk in Communities Investigators 1989) is a 
prospective investigation supported by the National Heart, 
Lung, and Blood Institute (NHLBI) of community dwellers to 
characterize the natural history of atherosclerosis and cardio-
vascular disease in 4 US communities (Jackson, Mississippi; 
Washington County, Maryland; suburban Minneapolis, 
Minnesota; and Forsyth County, North Carolina). The Jackson 
cohort was composed entirely of African Americans. A sample 
of 15,792 community-dwelling residents aged 45 to 64 y at 
baseline took part in an evaluation of cardiovascular risk fac-
tors and their sequelae. The Dental ARIC, an ancillary study 
funded by the National Institute of Dental and Craniofacial 
Research (NIDCR), was conducted during ARIC visit 4 (1996 
to 1999) and was cross-sectional in design. The Dental ARIC 
study consisted of an oral examination, collection of serum, 
and interviews among a diverse population of 6,793 middle-
aged adults. It includes measures of a serum marker of oxida-
tive stress (8-isoprostane), measures of levels of a panel of 
serum antibodies to oral bacteria, and clinical measures of total 
oral microbial load (i.e., plaque) and extent of periodontal dis-
ease. There were no exclusion criteria except for total edentu-
lism and need for antibiotic prophylaxis for the dental 
examination. Data were collected on factors known to contrib-
ute to oxidative stress (e.g., smoking and diabetes). The proto-
cols for this clinical investigation were reviewed and approved 
by the respective institutions’ institutional review boards.
Exposure Variables
Probing depth (PD) was assessed on 6 sites for all teeth. Plaque 
was measured using the Plaque Index (Löe 1967). The ARIC 
periodontal examiners were calibrated to a standard examiner, 
range for weighted κs was 0.86 to 0.94. Intraclass coefficients 
ranged from 0.87 to 0.95. Percent agreement within 1 mm 
ranged from 88.9% to 94.9%. We chose to focus our analysis 
using probing depths as a measure of periodontal status and 
plaque as a measure of microbial exposure. Among the clinical 
signs, PD was the single best predictor of serum IgG antibody 
levels. To create quartiles of extent scores, participants were 
ranked on the percentage of sites with PD ≥5 mm. Participants 
in the top quartile of number of sites with PD ≥5 mm were 
considered “high.” Participants in the remaining 3 quartiles of 
PD ≥5 mm extent were considered “low.”
Serum 8-Isoprostane
Direct 8-isoprostane PGF2α (d-8-iso PGF2α) is a stable end 
product of both specific inflammatory enzymatic pathways as 
well as nonspecific mechanisms and reflects total lipid peroxi-
dation, representing an excellent in vivo marker for oxidative 
stress (Sies 2000). The d-8-iso PGF2α assay was conducted on 
serum samples of ARIC subjects as previously described 
(Singer et al. 2009). Participants were ranked in quartiles based 
on their serum concentration of d-8-iso PGF2α.
Outcome Variables
The main outcome variables were serum CRP levels and serum 
IgG antibody levels to 16 selected periodontal organisms: 
Porphyromonas gingivalis, Prevotella intermedia, Prevotella 
nigrescens, Tannerella forsythia, Treponema denticola, 
Fusobacterium nucleatum, Aggregatibacter actinomycetem-
comitans, Campylobacter rectus, Micromonas micros, 
Veillonella parvula, Capnocytophaga ochracea, Selenomonas 
noxia, Actinomyces viscosus, Streptococcus intermedius, 
Streptococcus sanguis, and Streptococcus oralis. Serum sam-
ples collected as part of the ARIC examination were divided 
into aliquots at each examination site, frozen at –80°C, trans-
ported on dry ice to our laboratory, and stored in aliquots at 
–80°C. Samples were assayed for serum CRP levels using the 
high-sensitivity method described previously (Slade et al. 
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2003). Samples were assayed for IgG antibody levels directed 
against the 16 periodontal organisms using the checkerboard 
immunoblotting technique described by Sakellari et al. (1997).
Periodontal organisms selected were representatives from 
clusters of organisms associated with periodontal disease and 
health by Socransky et al. (1998). Summation scores for total 
serum IgG antibody level titers were made by summing IgG 
concentrations for each organism assayed.
Covariates
Participants were defined as never smokers, former smokers, 
or current smokers by interview. The former and current cate-
gories were further divided into light or heavy smokers, with 
light smokers reporting more than 0 but fewer than 20 pack-
years of smoking and heavy smokers reporting 20 or more 
pack-years of smoking. This scheme resulted in a 5-level cat-
egorization of smoking that takes into account both temporal-
ity and magnitude of smoking status as an exposure. Education 
was divided into basic (less than 12 years), intermediate (12 to 
16 years), or advanced (17 to 21 years) and was included to 
control for socioeconomic status. Age in years at visit 4 was 
included, and a variable representing race/ethnicity (African 
American or white) and ARIC center was designed to control 
for the ethnic, regional, and examiner differences in the ARIC 
cohort. Persons who were not African American or white and 
the few African Americans in the Maryland and Minnesota 
centers were excluded from analysis due to small numbers.
Participants fasted for 12 hours before the clinical examina-
tion, and blood was collected for plasma lipids including high-
density lipoprotein cholesterol (HDL), low-density lipoprotein 
cholesterol (LDL), triglycerides, and serum glucose. Diabetes 
mellitus was defined as fasting serum glucose ≥126 mg/dL 
(200 mg/dL if nonfasting), pharmacological treatment for dia-
betes, or being told by a doctor one has diabetes or sugar in the 
blood (self-reported).
Statistical Analysis
Statistical analyses and data management were performed 
using SAS (SAS Institute, Cary, NC, USA), statistical signifi-
cance was set at P ≤ 0.05, and the unit of analysis was the 
person. Frequency distributions, means, empirical distribution 
functions, and standard errors were determined to describe the 
data. When distributions were skewed, log transformations 
were applied. Bivariate relationships were investigated using 
t tests for continuous variables, as well as Cochran Mantel-
Haenszel χ2 statistics and odds ratios with 95% confidence 
intervals (CIs) for differences between categorical variables. 
Multivariable modeling was performed using SAS Proc GLM 
to calculate least squares means adjusting for other study vari-
ables. Potential confounders were specified a priori, based on 
the literature as being associated with either exposure or out-
comes. We explored effects of infections other than periodon-
tal disease (e.g., sinusitis, bronchitis, kidney disease, and 
pneumonia) and potential modifiers of oxidative stress (e.g., 
arthritis) on serum 8-isoprostane and CRP levels. We have only 
included in the analyses effect modifiers or confounders that 
influence the association by 5% or more, whether or not they 
were significant main effects.
Multivariate models were developed for serum CRP levels 
for each of the 16 oral biofilm IgG antibodies and 4 clusters of 
IgG antibodies that represent total biofilm IgG, total red IgG, 
total orange IgG, and total other IgG (Singer et al. 2009). The 
IgG clusters (i.e., other, orange, and red) were directed against 
microbial species associated with health, gingivitis, and peri-
odontitis, respectively (Sakellari et al. 1997). The models 
included demographic, behavioral, and medical variables iden-
tified in the χ2 models for serum levels of CRP, as well as plaque 
and pocket depth, and an interaction term for pocket depth and 
serum 8-isoprostane. The models compared serum CRP con-
centrations corresponding to quartiles of each of the 16 serum 
IgG antibodies and IgG antibody clusters. Models included all 
subjects with complete validated data sets for the indicated vari-
ables. Subjects with PD examinations + validated CRP, IgG, 
and 8-isoprostane bioassays totaled 4,567. The STROBE 
checklist was completed and its guidelines followed.
Results
Bivariate Associations for 8-Isoprostane, CRP, 
and Total Oral Biofilm IgG Antibody
To determine the factors related to serum concentrations of 
8-isoprostane, CRP, and total IgG antibody against the oral bio-
film microorganisms, bivariate analyses were conducted (Table 
1) for relevant clinical variables. Serum concentrations of 8- 
isoprostane above the median were associated with age, race/
field center, smoking, serum triglycerides, and pocket depth. 
While there was a relationship between smoking history and 
serum 8-isoprostane concentrations (Table 1), it was evident 
that current smokers had lower 8-isoprostane concentrations 
than former smokers, heavy smokers had lower 8-isoprostane 
levels than light smokers, and current heavy smokers had lower 
concentrations than nonsmokers. Mean serum CRP levels were 
associated with sex, race/field center, education, income, smoking, 
body mass index (BMI), diabetes, hypertension, serum LDL, 
triglycerides, pocket depth, plaque, and serum 8-isoprostane. 
As reported previously (Singer et al. 2009), mean total biofilm 
IgG antibody was related to sex, race/field center, smoking, 
BMI, hypertension, pocket depth, plaque, serum HDL, triglyc-
erides, and serum 8-isoprostane.
Serum 8-Isoprotane and Serum CRP Levels
In multivariate models (Table 2, left column) increasing quar-
tiles of 8-isoprostane were associated with significantly 
increased mean serum CRP levels. Multivariate models were 
then constructed comparing CRP levels between quartiles of 
increasing serum 8-isoprostane in subsets of subjects having 
“high” or “low” levels of periodontal pocket depth (Table 2, 2 
right columns). Quartiles of increasing serum 8-isoprostane 
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Table 1. Bivariate Analyses for Study Variables and Serum 8-Isoprostane, Total Oral Biofilm IgG Antibody, and CRP.
Log Median 8-Isoprostane LS Mean CRP







LS Mean CRP 
(SE) P Value
Mean Log  
Tot Biofilm  
IgG Ab (SE) P Value
Age <65 y 3,039 3.66 (1.23–5.75) 6.66 (0.22) 2.82 (0.01)  
 65+ y 1,678 3.93 (2.45–6.00) 0.0060 6.68 (0.29) 0.9701 2.83 (0.01) 0.7782
Sex Female 2,643 3.83 (1.23–6.00) 8.06 (0.26) 2.81 (0.01)  
 Male 2,074 3.67 (1.23–5.75) 0.0710 4.89 (0.22) <0.0001 2.85 (0.01) 0.0073
Race/field Mississippi 689 3.14 (2.56–4.42) 8.29 (0.05) 2.96 (0.02)  
 center North Carolina, AAs 117 3.79 (1.23–5.38) 10.61 (1.10) 3.01 (0.05)  
 North Carolina, whites 1,338 3.59 (2.62–5.67) 6.11 (0.33) 2.81 (0.01)  
 Maryland 1,339 3.48 (1.23–5.59) 5.98 (0.33) 2.77 (0.01)  
 Minnesota 1,234 4.71 (2.78–6.00) <0.0001 6.74 (0.34) <0.0001 2.81 (0.01) <0.0001
Years of 
education 
<11 y 631 3.50 (2.15–.30) 8.22 (0.47) 2.85 (0.02)  
12–16 y 2,065 3.78 (1.23–6.00) 6.82 (0.26) 2.81 (0.01)  
 >16 y 2,017 3.83 (1.58–6.00) 0.0476 6.03 (0.27) 0.0002 2.83 (0.01) 0.1400
Income ($) <25K 1,112 3.72 (2.11–5.73) 7.70 (0.36) 2.83 (0.02)  
 25K to <50K 1,669 3.82 (1.23–5.81) 7.02 (0.29) 2.83 (0.01)  
 50K+ 1,759 3.79 (1.23–6.00) 0.6532 5.72 (0.28) <0.0001 2.81 (0.01) 0.2801
Smoking Never 2,216 3.74 (1.23–5.77) 8.29 (0.25) 2.83 (0.01)  
 Former light 997 3.99 (2.18–6.00) 10.61 (0.38) 2.83 (0.02)  
 Former heavy 787 3.86 (2.52–6.00) 6.11 (0.42) 2.85 (0.02)  
 Current light 110 3.82 (2.69–6.00) 5.98 (1.13) 2.83 (0.05)  
 Current heavy 421 3.57 (1.23–5.69) 0.0461 6.74 (0.58) 0.0123 2.74 (0.03) 0.0114
BMI, kg/m2 <25 1,256 3.59 (1.23–5.71) 4.66 (0.33) 2.79 (0.01)  
 25 to <30 1,918 3.76 (1.72–6.00) 5.92 (0.27) 2.82 (0.01)  
 30 to <35 1,017 3.88 (2.06–6.00) 7.77 (0.37) 2.86 (0.02)  
 35+ 518 3.74 (2.61–5.73) 0.1528 12.05 (0.51) <0.0001 2.86 (0.02) 0.0028
Diabetes No 4,038 3.74 (1.23–5.98) 6.30 (0.18) 2.82 (0.01)  
 Yes 666 3.82 (2.54–5.86) 0.4516 8.88 (0.54) <0.0001 2.84 (0.02) 0.2526
Hypertension No 3,108 3.73 (1.23–5.81) 5.86 (0.20) 2.81 (0.01)  
 Yes 1,585 3.80 (2.27–6.00) 0.5102 8.18 (0.34) <0.0001 2.86 (0.01) 0.0020
LDL Low 2,897 3.78 (1.23–6.00) 6.99 (0.23) 2.83 (0.01)  
 High 1,818 3.72 (1.23–5.79) 0.4087 6.15 (0.26) 0.0187 2.81 (0.01) 0.2168
HDL Low 3,882 3.73 (1.23–5.75) 6.77 (0.20) 2.82 (0.01)  
 High 835 3.94 (2.57–6.00) 0.2344 6.20 (0.36) 0.2165 2.86 (0.02) 0.0232
Triglycerides Low 2,715 3.50 (1.23–5.41) 6.04 (0.22) 2.84 (0.01)  
 High 2,002 4.16 (2.66–6.00) <0.0001 7.52 (0.28) <0.0001 2.80 (0.01) 0.0047
Pocket depth Low PD (extent 5 mm 
PD, Q1–Q3)
3,521 3.67 (1.23–6.00) 6.29 (0.18) 2.81 (0.01)  
 High PD (extent 5 mm 
PD, Q4)
1,149 3.88 (1.84–5.74) 0.0382 7.70 (0.43) 0.0005 2.87 (0.01) 0.0003
Plaque Low plaque (extent PI, 
Q1–Q3)
3,346 3.81 (1.23–6.00) 6.28 (0.20) 2.81 (0.01)  
 High plaque (extent 
PI, Q4)




1 NA NA 4.46 (0.34) 2.94 (0.01)  
2 NA NA 5.83 (0.35) 2.89 (0.01)  
3 NA NA 7.95 (0.34) 2.77 (0.01)  
 4 NA NA 8.44 (0.34) <0.0001 2.69 (0.02) <0.0001
AAs, African Americans; BMI, body mass index; CRP, C-reactive protein; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein 
cholesterol; LS, least squares; NA, not applicable; PD, pocket depth; PI, Plaque Index; Q1, quartile 1, Q2, quartile 2; Q3, quartile 3; Q4, quartile 4; SE, 
standard error.
concentration were associated with significant increases in 
serum CRP levels in subjects with either “high” or “low” 
pocket depth. “High” pocket depth was associated with 
increased serum CRP levels only among subjects within the 
top quartile of serum 8-isoprostane level.
Interaction of Serum IgG Antibody  
Levels with Serum CRP
There were significant differences in serum CRP concentrations 
between multivariate models for quartiles of decreasing levels 
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of 16 serum IgG antibodies and the IgG antibody clusters. 
Quartiles of individual IgG antibodies clustered into 3 groups 
(Fig. 1). In the first group (IgGs: Pi, Pn, So, Pg, and Sn), IgG 
quartiles Q1, Q2, and Q3 had significantly greater CRP levels 
than did Q4, the quartile with the highest concentration of IgG 
antibody. In the second group (IgGs: Td, Cr, Si, and Fn), at least 
1 IgG quartile (Q1, Q2, or Q3) had higher CRP than did Q4. In 
the third group (IgGs: Tf, Co, Mm, Vp, Aa, Av, and Ss), no IgG 
quartile had a CRP level greater than in Q4. Quartiles of 
decreasing levels of total Biofilm, red, orange, and other IgG 
antibodies (Table 3) were associated with increased serum CRP 
levels. The differences between CRP concentrations in quartiles 
3 and 4 were significant for the total and red IgG clusters but not 
for the orange and other IgG clusters.
Discussion
Findings reported here support our hypothesis that increased 
oxidative stress modifies the association between periodontitis 
and serum CRP. The association between periodontitis and CRP 
appears only in the presence of high oxidative stress and is con-
comitantly associated with a suppression of serum IgG. Also, 
increased serum IgG antibodies to oral bacteria are associated 
with decreased serum CRP concentrations. Thus, physiologic 
Table 2. Adjusted Mean CRP Levels by Quartiles of Serum 8-Isoprostane and by Extent of PD of ≥5 mm.
Mean CRP (SE)a Mean CRP (SE)b  
Quartiles of Serum 
8-Isoprostane Overall P Value vs Quartile 1
Extent 5 mm PD in 
Bottom 3 Quartiles
Extent 5 mm PD in Top 
Quartile Pr > |t|c
1 4.74 (0.35) Referent 4.58 (0.40) 5.27 (0.74) 0.41
2 5.76 (0.35) 0.04 5.77 (0.40)* 5.64 (0.76) 0.88
3 7.71 (0.35) <0.0001 7.39 (0.41)*,** 8.82 (0.68)*,** 0.08
4 8.35 (0.36) <0.0001 7.62 (0.40)*,** 10.67 (0.74)*,**,† 0.0003
CRP, C-reactive protein; PD, pocket depth; SE, standard error.
aAdjusted for race/center, sex, body mass index (BMI), age, smoking, diabetes, hypertension, education, income, pocket depth, plaque, and serum low-
density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), and triglycerides (n = 4,231).
bAdjusted for race/center, sex, BMI, age, smoking, diabetes, hypertension, education, income, plaque, LDL, HDL, and triglycerides (n = 4,231). 
Significantly different (P < 0.05) from indicated quartile (i.e., quartile 1 = *, quartile 2 = **, or quartile 3 = †) of 8-isoprostane.
cProbability of difference between mean CRP for subsets of extent 5 mm PD in bottom 3 quartiles vs. extent 5 mm PD in top quartile at indicated 










Pi Pn So Pg Sn Td Cr Si Fn Tf Co Mm Vp Aa Av Ss 
IgG Antibodies to Indicated Bacterial species
(Stratified into quartiles then clustered according to CRP responses. Pi: P. intermedia; Pn: P. 
nigrescens; So: S.oralis; Pg: P. gingivalis; Sn: S. noxia; Td: T. denticola; Cr: C. rectus; Si: S. 
intermedius; Fn: F. nucleatum; Tf: T. forsythia; Co: C. ochracea; Mm: M. micros; Vp: 
V.parvoula; Aa: A. Actinomycetemcomitans; Av: A.viscosis; Ss: S. sanguis)











Figure 1. Associations between serum IgG antibodies and serum C-reactive protein (CRP) levels. IgG antibodies against each of 16 bacterial species 
are shown stratified into quartiles (Q1–Q4) of IgG concentration versus serum CRP concentrations (µg/mL). Organism titers are grouped according to 
response and significance. Three distinct antibody response patterns are shown (Pi, Pn, So, Pg, and Sn; Td, Cr, Si, and Fn; Tf, Co, Mm, Vp, Aa, Av, and 
Ss). All models were adjusted for race/center, age, sex, body mass index, income, education, smoking, low-density lipoprotein cholesterol, high-density 
lipoprotein cholesterol, triglycerides, pocket depth, and plaque comparing the lowest titer (Q4) to Q1 to Q3, with * indicating significant difference  
(P ≤ 0.01). n = 4,226 for all except Aa, Pg, Pn, and Pi (n = 4,225); Td (n = 4,224); Av (n = 4,216); and Tf (n = 4,103).
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differences in serum 8-isoprostane levels 
appear to modify systemic acute phase 
and serum IgG antibody responses and 
their association(s) with periodontitis. 
This suggests that oxidative stress level 
might modify the intrinsic risk from sys-
temic exposure to the oral microflora by 
suppressing serum IgG.
The findings in this report suggest a 
mechanistic model that appears in Figure 
2. Specifically, oxidative stress shifts Th 
cell and antigen-presenting cell responses 
such that Th-1 cell and plasma cell func-
tions likely become impaired (Singer et al. 
2009), thereby decreasing IgG antibody 
responses against oral bacteria. Decreased 
serum-neutralizing IgG antibodies to oral 
bacteria enable plaque microbial toxins/
molecules to enter the circulation and/or 
increase release of cytokines from the 
inflamed periodontium. Either outcome 
could induce systemic inflammatory 
mediators that prompt expression and 
release of acute phase reactants (e.g., 
CRP) from the liver and other tissues.
Although data presented here are 
cross-sectional in nature and only demon-
strate associations, other investigations 
support this model. For example, Qin 
et al. (2014) demonstrate a series of oral 
bacteria genera (e.g., Streptococcus and 
Prevotella species) become prominent in 
the human gut microbiome in association 
with liver cirrhosis. Liver cirrhosis is 
associated with elevated serum CRP (Tilg et al. 1992) and 8-iso-
prostane (Aboutwerat et al. 2003) levels. Our finding (Fig. 1) 
that IgG antibodies to Streptococcus and Prevotella species are 
among the most potent in modifying serum CRP levels indicates 
a parallel between these findings and suggests hepatic function/
dysfunction may be connected to levels of specific oral bacteria, 
IgG antibodies against those bacteria, and serum 8-isoprostane.
In cross-sectional studies, increased serum concentrations 
of 8-isoprostane have been correlated with increased levels of 
serum CRP in patients with end-stage renal disease (Lim et al. 
2002), stroke patients (Sánchez-Moreno et al. 2004), and a 
healthy adult population (Dohi et al. 2007). Our findings indi-
cate physiologic increases in serum 8-isoprostane concentra-
tions relate to significant increases in serum CRP levels in a 
representative adult population. It is possible that lipid-based 
oxidative stress facilitates signaling pathways initiated by 
serum cytokine mediators (e.g., interleukin [IL]–6, IL-1, or 
tumor necrosis factor–α) induced by systemic exposure of the 
Table 3. Adjusted Mean Serum CRP Levels According to Quartiles of Serum IgG Antibody vs. Clusters of Oral Bacteria.a
Mean (SE) Serum CRP Concentration
 Quartiles of IgG Antibodies
P Value for Indicated Comparison of Serum IgG 
Antibody Quartiles
Antibody Clusters 1 2 3 4 Q1–Q4 Q2–Q4 Q3–Q4
Total biofilm IgG 7.58 (0.37) 7.47 (0.36) 6.32 (0.36) 5.28 (0.36) <0.0001 <0.0001 0.0415
Total red IgG 7.50 (0.36) 6.71 (0.36) 6.99 (0.36) 5.42 (0.36) <0.0001 0.0124 0.0021
Total orange IgG 7.71 (0.36) 7.34 (0.36) 6.07 (0.35) 5.52 (0.35) <0.0001 0.0003 0.2653
Total other IgG 7.48 (0.36) 7.02 (0.36) 6.27 (0.35) 5.85 (0.35) 0.0012 0.019 0.3918
CRP, C-reactive protein; SE, standard error.
aAdjusted for race/center, age, sex, body mass index, income, education, smoking, low-density lipoprotein cholesterol, high-density lipoprotein 
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Figure 2. Oxidative stress suppresses IgG response to pathogenic bacteria. Reactive oxygen 
species (ROS) are produced by activated phagocytes as their defense against pathogens. External 
stressors such as diet, smoking, and diabetes increase reactive oxygen species as well. Excessive 
burden of these oxidants will attenuate IgG synthesis, leading to compromised local clearance of 
pathogens. The increase of serum C-reactive protein shows correlation with periodontitis only 
when there is such overburden of ROS.
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oral biofilm microflora (and/or other systemic inflammatory 
stimuli). In vitro studies show CRP expression is enhanced in 
the presence of elevated NF-κB expression (Voleti and Agrawal 
2005; Bode et al. 2012), and NF-κB–mediated gene expression 
is increased by oxidative stress in hepatocytes (Gong et al. 
2001) and other cell types (Li and Karin 1999).
Our multivariate models (Table 3) demonstrate that high 
levels of the total, other, orange, and red IgG antibody clusters 
(and 9 of 16 IgG serum antibodies) are associated with signifi-
cantly lower serum CRP levels. This suggests that perhaps 
serum IgG antibodies to oral bacteria prevent signaling pro-
cesses leading to expression of CRP (Fig. 2). The finding sup-
ports the concept that IgG antibodies to periodontal pathogens 
have the strongest effects on CRP levels, although modulating 
effects on CRP levels are not exclusive to those antibodies 
(Table 3 and Fig. 1). Periodontal pathogens can advance peri-
odontal pathology, break down periodontal barrier functions, 
invade the periodontium, and lead to bacteremia. Our findings, 
however, indicate other oral bacteria (e.g., So and Sn) and IgG 
antibodies against them also are important modifiers of serum 
CRP responses. Perhaps periodontal pathology prompted by 
periodontal pathogens enables systemic exposure of other oral 
bacteria potent in prompting CRP responses. CRP is named for 
its interaction with Streptococcus antigens (Pepys and 
Hirschfield 2003), and a connection of Streptococcus species 
with liver function/dysfunction is evident from other investiga-
tions (Qin et al. 2014). Our findings also are consistent with the 
concept (Kinane et al. 2015) that subject populations differ in 
the ability to contain periodontal inflammation to a localized 
response as opposed to a systemic response.
This investigation is limited by our use of secondary analy-
ses of data that are cross-sectional in nature. However, this is a 
large population-based data set that includes measures of oxi-
dative stress, serum IgG antibodies, and CRP using methods 
that are well established and informative.
Together, these findings suggest systemic oxidative stress 
(at the lipid level) and serum IgG antibody levels to oral bacte-
ria are important modifiers of systemic acute phase responses 
to the oral microflora and periodontitis (Fig. 2). The effects of 
systemic oxidative stress and serum IgG antibodies function in 
opposing directions in modifying serum CRP levels and indeed 
have an inverse relationship between each other. In studies not 
shown here, we found ARIC subjects with serum 8-isoprostane 
levels above the median and having elevated (>median) IgG 
antibodies to Pi and Pn had decreased (P < 0.05) serum CRP, 
while for subjects with serum 8-isoprostane below the median, 
having increased IgG antibodies to Pi, So, and Sn was associ-
ated with decreased CRP. This suggests oxidative stress also is 
related to qualitative changes in the profile of IgG antibodies 
modifying serum CRP levels. Defining quantitative and quali-
tative effects of oxidative stress on IgG antibody responses to 
oral bacteria and their modification of CRP responses will be a 
rich area for research to define mechanistic pathways connect-
ing periodontitis to systemic inflammation, inflammatory dis-
eases, and perhaps clinical outcomes.
Our findings may help to explain differences in the litera-
ture regarding the response of serum CRP levels to periodontal 
therapy (Ioannidou et al. 2006). That is, physiologic differ-
ences in serum levels of 8-isoprostane in a community-based 
population were associated with significant differences in 
baseline serum CRP, serum IgG antibodies to oral bacteria, and 
the association of CRP with periodontitis. Without accounting 
for these population variables (or key variables in our multi-
variate models), demonstrating an impact of periodontal ther-
apy on serum CRP levels could prove difficult.
Increased serum levels of 8-isoprostane have been associ-
ated with clinical outcomes in atherosclerosis (Mueller et al. 
2004) and preterm birth clinical trials (Parra et al. 2005). The 
findings presented here suggest serum levels of 8-isoprostane 
may be a useful variable for the identification of patient popu-
lations wherein periodontitis would be a risk factor for 
increased systemic inflammation and consequent clinical out-
comes. Clinical trials focused on the role of periodontitis in 
systemic inflammation, and systemic diseases may benefit 
from controlling for this variable and/or using it to identify 
subpopulations wherein periodontitis presents the greatest risk 
for systemic disease.
Dietary levels of antioxidants and flavonoids have been 
related to decreased serum CRP levels in various patient popu-
lations (Devaraj and Jialal 2000; Prasad 2006; Chun et al. 
2008; di Giuseppe et al. 2008; Block et al. 2009). Together 
with our findings, this suggests intervention strategies target-
ing oxidative signaling pathways may modify systemic 
immune and inflammatory responses to periodontitis and merit 
further exploration.
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